Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Pathology|July 15, 2010
The biological and clinical value of p53 expression in pelvic high-grade serous carcinomasMartin Köbel, Alexander Reuss, Andreas du Bois, et al.
The American Journal of Surgical Pathology|October 3, 2008
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovaryMartin Köbel, Steve E Kalloger, Jon Carrick, et al.
Clinical & Experimental Metastasis|January 21, 2012
The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinomaJane A Cipollone, Marcia L Graves, Martin Köbel, et al.
Gynecologic Oncology|October 30, 2012
Quantification of ER/PR expression in ovarian low-grade serous carcinomaJorge Escobar, Alexander C Klimowicz, Michelle Dean, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 29, 2013
Reproducibility of histological cell type in high-grade endometrial carcinomaGuangming Han, Davinder Sidhu, Máire A Duggan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 11, 2012
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinomaJames P Beirne, Jennifer E Quinn, Perry Maxwell, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 27, 2019
Immunohistochemistry Critical Assay Performance Controls (ICAPC) Reduce Interobserver Variability in the Interpretation of BRAFV600E ImmunohistochemistryNadia S Gale, Steve E Kalloger, Ellen Cai, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|July 1, 2006
Tomographic comparison of ventilation techniques for CT-guided thoracoscopic staple excision of subcentimeter lung nodulesHumberto Lara-Guerra, Steve E Kalloger, Tom Powell, et al.
Journal of Clinical Pathology|October 27, 2015
Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroupsJoyce M Leo, Steve E Kalloger, Renata D Peixoto, et al.
Pageof 9